نتایج جستجو برای: pharmaceutical companies

تعداد نتایج: 139191  

Journal: :The American journal of cardiology 2013
Vincent E Friedewald Christie M Ballantyne Harold E Bays Peter H Jones

Dr. Friedewald has no conflicts to disclose. Dr Ballantyne has received research grants and honoraria from Amarin Pharma, Inc. and has also received research grants and served as a consultant and speaker for numerous other pharmaceutical companies. Dr. Bays has received research grants and served as an adviser to Amarin Pharma Inc. and has also received research grants and served as a consultan...

Journal: :Drug discovery today 2006
Neil Kumar Bart S Hendriks Kevin A Janes David de Graaf Douglas A Lauffenburger

Computational models of cells, tissues and organisms are necessary for increased understanding of biological systems. In particular, modeling approaches will be crucial for moving biology from a descriptive to a predictive science. Pharmaceutical companies identify molecular interventions that they predict will lead to therapies at the organism level, suggesting that computational biology can p...

1999
M. Lisa Swoboda

I began to wonder about the larger question of whether there was any ethical obligation of these pharmaceutical companies to develop, produce or supply medicinal products to markets that either cannot afford them or that are too small to bring a return on the investment. After all, few would argue that a computer company has a moral obligation to develop a product for a small unprofitable marke...

2006
Sung J. Shim

INTRODUCTION The pharmaceutical industry in the United States spends about $15 billion per year advertising its products to the medical profession [1]. Pharmaceutical detailing, which is using sales representatives to call on physicians to promote products, accounts for about 45 percent of this spending [2]. In order to help sales representatives track sales leads, sales, service requests, and ...

Journal: :Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 2003
Claude Le Pen

OBJECTIVES The objectives of this study were to give a review of the complex system of budgetary constraints to which the French health-care system has been committed since 1996 and to evaluate the consequences on drug policy and on efficient use of pharmaceuticals. METHODS Literature review, legal texts analysis, and interviews with policy makers and companies managers were performed. RESU...

2016
Marissa King Peter S. Bearman

The pharmaceutical industry spends roughly 15 billion dollars annually on detailing – providing gifts, samples, free pens, trips, honoraria and other inducements – to physicians in order to encourage them to prescribe their drugs. In response, a movement to regulate pharmaceutical marketing emerged. In this article, we use a dataset that captures 189 million psychotropic prescriptions written i...

Journal: :Indian heart journal 2015
Sivasubramanian Ramakrishnan

Indian pharmaceutical industry is successfully following the ‘make in India’ theme, much before it became a buzz word in governance. India has dominated themanufacturing of generic and bio-similar drugs. A few of the Indian companies have made anti-tubercular, anti-retroviral and anti-cancer drugs available to the vast majority of the world population at a fractionof thecostof theirpatentedcoun...

Journal: :Food and drug law journal 1996
P S Reichertz

The promotion of pharmaceutical products on the internet, an unforeseen event only a few years ago, has begun. While some companies only have registered domain sites with Internic, others have set up home pages that deal with pharmaceutical products such as Rogaine (minoxidil), a drug product approved to promote the growth of hair; Claritin (loratidine), a prescription nonsedating antihistamine...

2012
G Orzan IA Zara VL Purcarea

Recent years have seen an "explosion" in the abilities of scientists to use neuroscience in new domains. Unfortunately, it is little known and reported on how advertising companies make more effective pharmaceutical drugs commercials. The purpose of this paper is to analyze how neuromarketing techniques may impact the consumer response to pharmaceutical advertising campaigns. The result shows t...

2017
Evelien Moorkens Nicolas Meuwissen Isabelle Huys Paul Declerck Arnold G. Vulto Steven Simoens

Background: Biopharmaceutical medicines represent a growing share of the global pharmaceutical market, and with many of these biopharmaceutical products facing loss of exclusivity rights, also biosimilars may now enter the biopharmaceutical market. Objectives: This study aims to identify and document which investment and development strategies are adopted by industrial players in the global bio...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید